OTC Markets OTCPK - Delayed Quote USD

Encision Inc. (ECIA)

Compare
0.4000
-0.0100
(-2.44%)
At close: January 14 at 1:55:12 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
6,492.4260
6,585.8820
7,348.5140
7,668.6360
7,537.8340
Cost of Revenue
3,310.6530
3,449.9200
3,315.9810
3,880.2180
3,632.7310
Gross Profit
3,181.7730
3,135.9620
4,032.5330
3,788.4180
3,905.1030
Operating Expense
3,831.2810
3,776.7450
4,335.3300
4,383.3520
3,966.7440
Operating Income
-649.5080
-640.7830
-302.7970
-594.9340
-61.6410
Net Non Operating Interest Income Expense
-48.2570
-62.3730
-19.5290
-7.2240
-87.1270
Other Income Expense
5.7430
11.3730
-1.6190
536.5640
733.5020
Pretax Income
-692.0220
-691.7830
-323.9450
-65.5940
584.7340
Net Income Common Stockholders
-692.0220
-691.7830
-323.9450
-65.5940
584.7340
Diluted NI Available to Com Stockholders
-692.0220
-691.7830
-323.9450
-65.5940
584.7340
Basic EPS
-0.06
-0.06
-0.03
-0.01
0.05
Diluted EPS
-0.06
-0.06
-0.03
-0.01
0.05
Basic Average Shares
11,823.1920
11,770.3910
11,763.0000
11,625.0000
11,583.0000
Diluted Average Shares
11,823.1920
11,770.3910
11,763.0000
11,625.0000
11,768.0000
Total Operating Income as Reported
-649.5080
-640.7830
-302.7970
-594.9340
-61.6410
Total Expenses
7,141.9340
7,226.6650
7,651.3110
8,263.5700
7,599.4750
Net Income from Continuing & Discontinued Operation
-692.0220
-691.7830
-323.9450
-65.5940
584.7340
Normalized Income
-692.0220
-691.7830
-323.9450
-598.7120
-13.8330
Interest Expense
48.2570
62.3730
19.5290
7.2240
87.1270
Net Interest Income
-48.2570
-62.3730
-19.5290
-7.2240
-87.1270
EBIT
-643.7650
-629.4100
-304.4160
-58.3700
671.8610
EBITDA
-559.7970
-544.1920
-217.5100
55.1000
760.8160
Reconciled Cost of Revenue
3,310.6530
3,449.9200
3,315.9810
3,880.2180
3,632.7310
Reconciled Depreciation
83.9680
85.2180
86.9060
113.4700
88.9550
Net Income from Continuing Operation Net Minority Interest
-692.0220
-691.7830
-323.9450
-65.5940
584.7340
Total Unusual Items Excluding Goodwill
--
--
--
533.1180
598.5670
Total Unusual Items
--
--
--
533.1180
598.5670
Normalized EBITDA
-559.7970
-544.1920
-217.5100
-478.0180
162.2490
3/31/2021 - 1/2/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MHUA Meihua International Medical Technologies Co., Ltd.
0.3169
-0.25%
 
CEOS Psykey, Inc.
0.0178
-19.09%
 
NXGL NEXGEL, Inc.
3.4500
-2.27%
 
HBIO Harvard Bioscience, Inc.
2.0200
+2.02%
 
STSS Sharps Technology, Inc.
1.9400
-3.96%
 
INND InnerScope Hearing Technologies, Inc.
0.0200
-24.53%
 
RVP Retractable Technologies, Inc.
0.7570
+0.29%
 
MLSS Milestone Scientific Inc.
1.0900
+0.93%
 
LUCY Innovative Eyewear, Inc.
5.73
+2.50%
 
EKSO Ekso Bionics Holdings, Inc.
0.6942
-2.51%